Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The incidence of skin lesions in contrast media-induced chemical hypersensitivity

  • Authors:
    • Andrei Mihai Iordache
    • Anca Oana Docea
    • Ana Maria Buga
    • Radu Mitrut
    • Dana Albulescu
    • Ovidiu Zlatian
    • Simona Ianosi
    • Gabriel Ianosi
    • Daniela Neagoe
    • Maria Sifaki
    • Otilia Constantina Rogoveanu
    • Daciana Elena Branisteanu
    • Daniela Calina
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Radiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Laboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, Crete, Greece, Department of Physical Medicine and Rehabilitation, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Dermatology, University of Medicine and Pharmacy ‘Gr. T. Popa’, 700115 Iasi, Romania
    Copyright: © Iordache et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1113-1124
    |
    Published online on: December 5, 2018
       https://doi.org/10.3892/etm.2018.7056
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Contrast agents are used in radiology to increase the sensibility and specificity of radiological techniques. Some of these compounds have side effects that include organ toxicity (with kidney being the most affected organ) and hypersensitivity reactions. We performed multiple PubMed searches from January, 2008 to January, 2018 for studies regarding adverse reactions to compounds used as contrast agents in imagistic techniques. The initial research identified 929 records written in English. After further excluding 223 non-human studies, 292 articles that had irrelevant designs as reviews, meta-analysis, commentaries, editorials and case reports, 414 studies were selected for retrieval. After reading the abstracts, we excluded 363 studies as they had little relevance to the study. In total, 51 full-articles were assessed for eligible studies to be included. Finally, 20 articles were included in the analysis. In our systematic literature search the incidence of overall skin immediate reactions to iodinated contrast media (ICM) had an incidence between 1.15 and 0.12%, depending on the cohort analyzed in the studies. The percentage of cutaneous manifestations in the cohort that experienced immediate hypersensitivity reactions was between 33.33 and 87.7%. The most frequent skin manifestations were urticaria, rashes, pruritus and limited facial edema. Non-iodinated contrast agents have a safer profile compared with ICM, the incidence of immediate adverse reactions being very low in gadolinium-based contrast agents and other agents used for contrast-enhanced ultrasound. The incidence of delayed reactions was between 10.1 and 0.03%. In the studies analyzed by us the main adverse reactions due to delayed hypersensitivity phenomena were cutaneous manifestations that were present between 70.27 and 100% of the cases. Regarding the risk factors for developing immediate adverse reactions, being female was a predisposing factor accompanied by history of allergy and history of reactions to contrast media. An accurate anamnesis of the patients and a correctly conducted pretreatment can limit the incidence and the severity of the adverse reactions and also can avoid the life occurrence of life-threatening reactions.
View Figures

Figure 1

Figure 2

View References

1 

Filler A: The History, development and impact of computed imaging in neurological diagnosis and neurosurgery: CT, MRI, and DTI. Nat Preced. 7:pp. 1–76. 2009, https://doi.org/10.1038/npre.2009.3267

2 

Singh J and Daftary A: Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 36:69–77. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Hasegawa M and Gomi T: Radiological contrast agents and radiopharmaceuticals. Side Effects of Drugs Annual. Ray SD: 37. 1st. Elsevier; Amsterdam: pp. 583–593. 2015, View Article : Google Scholar

4 

Iyer RS, Schopp JG, Swanson JO, Thapa MM and Phillips GS: Safety essentials: Acute reactions to iodinated contrast media. J Can Assoc Radiol. 64:193–199. 2013. View Article : Google Scholar

5 

Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C and Tsatsakis A: Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 180:99–112. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Sodagari F, Mozaffary A, Wood CG III, Schmitz B, Miller FH and Yaghmai V: Reactions to both nonionic iodinated and gadolinium-based contrast media: Incidence and clinical characteristics. AJR Am J Roentgenol. 210:715–719. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Nicola R, Shaqdan KW, Aran S, Prabhakar AM, Singh AK and Abujudeh HH: Contrast media extravasation of computed tomography and magnetic resonance imaging: Management guidelines for the radiologist. Curr Probl Diagn Radiol. 45:161–164. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Fok JS and Smith WB: Hypersensitivity reactions to gadolinium-based contrast agents. Curr Opin Allergy Clin Immunol. 17:241–246. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Morales-Cabeza C, Roa-Medellin D, Torrado I, De Barrio M, Fernández-Álvarez C, Montes-Aceñero JF, De La Riva I and Prieto-García A: Immediate reactions to iodinated contrast media. Ann Allergy Asthma Immunol. 119:553–557. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Kim SR, Lee JH, Park KH, Park HJ and Park JW: Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography. Clin Exp Allergy. 47:106–112. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Zhang BC, Hou L, Lv B and Xu YW: Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices. Br J Radiol. 87:201303252014. View Article : Google Scholar : PubMed/NCBI

12 

García M, Aguirre U, Martinez A, Ruiz B, Lertxundi U and Aguirre C: Acute adverse reactions to iopromide vs iomeprol: A retrospective analysis of spontaneous reporting from a radiology department. Br J Radiol. 87:201305112014. View Article : Google Scholar : PubMed/NCBI

13 

Kalaiselvan V, Sharma S and Singh GN: Adverse reactions to contrast media: An analysis of spontaneous reports in the database of the pharmacovigilance programme of India. Drug Saf. 37:703–710. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Pradubpongsa P, Dhana N, Jongjarearnprasert K, Janpanich S and Thongngarm T: Adverse reactions to iodinated contrast media: Prevalence, risk factors and outcome-the results of a 3-year period. Asian Pac J Allergy Immunol. 31:299–306. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Ho J, Kingston RJ, Young N, Katelaris CH and Sindhusake D: Immediate hypersensitivity reactions to IV non-ionic iodinated contrast in computed tomography. Asia Pac Allergy. 2:242–247. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Mitchell AM, Jones AE, Tumlin JA and Kline JA: Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare. Acad Emerg Med. 18:1005–1009. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Goksel O, Aydın O, Atasoy C, Akyar S, Demirel YS, Misirligil Z and Bavbek S: Hypersensitivity reactions to contrast media: Prevalence, risk factors and the role of skin tests in diagnosis - a cross-sectional survey. Int Arch Allergy Immunol. 155:297–305. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Häussler MD: Safety and patient comfort with iodixanol: A postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations. Acta Radiol. 51:924–933. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Lapi F, Cecchi E, Pedone C, Attanasio F, Banchelli G, Vannacci A, Di Pirro M, Moschini M, Berni V, Matucci R, et al: Safety aspects of iodinated contrast media related to their physicochemical properties: A pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol. 64:723–737. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Torres A, Koskinen SK, Gjertsen H and Fischler B: Contrast-enhanced ultrasound using sulfur hexafluoride is safe in the pediatric setting. Acta Radiol. 58:1395–1399. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Yusuf GT, Sellars ME, Deganello A, Cosgrove DO and Sidhu PS: Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol. 208:446–452. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Granata V, Cascella M, Fusco R, dell'Aprovitola N, Catalano O, Filice S, Schiavone V, Izzo F, Cuomo A and Petrillo A: Immediate adverse reactions to gadolinium-based MR contrast media: A retrospective analysis on 10,608 examinations. BioMed Res Int. 2016, pp. 39182922016. doi.org/10.1155/2016/3918292. PubMed/NCBI

23 

Power S, Talbot N, Kucharczyk W and Mandell DM: Allergic-like reactions to the MR imaging contrast agent gadobutrol: A prospective study of 32 991 consecutive injections. Radiology. 281:72–77. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH and Cho SH: Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology. 264:414–422. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Emond S and Brunelle F: Gd-DOTA administration at MRI in children younger than 18 months of age: Immediate adverse reactions. Pediatr Radiol. 41:1401–1406. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Prince MR, Zhang H, Zou Z, Staron RB and Brill PW: Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol. 196:138–143. 2011. View Article : Google Scholar

27 

Wallace MB, Meining A, Canto MI, Fockens P, Miehlke S, Roesch T, Lightdale CJ, Pohl H, Carr-Locke D, Löhr M, et al: The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 31:548–552. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Loh S, Bagheri S, Katzberg RW, Fung MA and Li CS: Delayed adverse reaction to contrast-enhanced CT: A prospective single-center study comparison to control group without enhancement. Radiology. 255:764–771. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P and Matsuura K: Adverse reactions to ionic and nonionic contrast media. A report from the Japanese committee on the safety of contrast media. Radiology. 175:621–628. 1990. View Article : Google Scholar : PubMed/NCBI

30 

Wolf GL, Arenson RL and Cross AP: A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: Comparison of adverse effects. AJR Am J Roentgenol. 152:939–944. 1989. View Article : Google Scholar : PubMed/NCBI

31 

Palmer FJ: The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol. 32:426–428. 1988. View Article : Google Scholar : PubMed/NCBI

32 

Caro JJ, Trindade E and McGregor M: The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: A meta-analysis. AJR Am J Roentgenol. 156:825–832. 1991. View Article : Google Scholar : PubMed/NCBI

33 

Idée JM, Pinès E, Prigent P and Corot C: Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol. 19:263–281. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Boyd B, Zamora CA and Castillo M: Managing adverse reactions to contrast agents. Magn Reson Imaging Clin N Am. 25:737–742. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Kirchin MA and Runge VM: Contrast agents for magnetic resonance imaging: Safety update. Top Magn Reson Imaging. 14:426–435. 2003. View Article : Google Scholar : PubMed/NCBI

36 

Ersoy H and Rybicki FJ: Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 26:1190–1197. 2007. View Article : Google Scholar : PubMed/NCBI

37 

Nelson KL, Gifford LM, Lauber-Huber C, Gross CA and Lasser TA: Clinical safety of gadopentetate dimeglumine. Radiology. 196:439–443. 1995. View Article : Google Scholar : PubMed/NCBI

38 

Piscaglia F and Bolondi L: Italian society for ultrasound in medicine and biology (SIUMB) study group on ultrasound contrast agents: The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol. 32:1369–1375. 2006. View Article : Google Scholar : PubMed/NCBI

39 

Yasuda R and Munechika H: Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol. 33:1–5. 1998. View Article : Google Scholar : PubMed/NCBI

40 

Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K and Katayama H: A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol. 13:185–194. 2003.PubMed/NCBI

41 

Rydberg J, Charles J and Aspelin P: Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium. Acta Radiol. 39:219–222. 1998. View Article : Google Scholar : PubMed/NCBI

42 

Panto PN and Davies P: Delayed reactions to urographic contrast media. Br J Radiol. 59:41–44. 1986. View Article : Google Scholar : PubMed/NCBI

43 

Akiyama M, Nakada T, Sueki H, Fujisawa R and Iijima M: Drug eruption caused by nonionic iodinated X-ray contrast media. Acad Radiol. 5:159–161. 1998. View Article : Google Scholar

44 

Reynolds NJ, Wallington TB and Burton JL: Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol. 129:82–85. 1993. View Article : Google Scholar : PubMed/NCBI

45 

Good AE, Novak E and Sonda LP III: Fixed eruption and fever after urography. South Med J. 73:948–949. 1980. View Article : Google Scholar : PubMed/NCBI

46 

Savill JS, Barrie R, Ghosh S, Muhlemann M, Dawson P and Pusey CD: Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. J Postgrad Med. 64:392–394. 1988. View Article : Google Scholar

47 

Rosado A, Canto G, Veleiro B and Rodríguez J: Toxic epidermal necrolysis after repeated injections of iohexol. AJR Am J Roentgenol. 176:262–263. 2001. View Article : Google Scholar : PubMed/NCBI

48 

Kanny G, Pichler W, Morisset M, Franck P, Marie B, Kohler C, Renaudin JM, Beaudouin E, Laudy JS and Moneret-Vautrin DA: T cell-mediated reactions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol. 115:179–185. 2005. View Article : Google Scholar : PubMed/NCBI

49 

Voth M, Rosenberg M and Breuer J: Safety of gadobutrol, a new generation of contrast agents: Experience from clinical trials and postmarketing surveillance. Invest Radiol. 46:663–671. 2011.PubMed/NCBI

50 

Lang DM, Alpern MB, Visintainer PF and Smith ST: Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med. 153:2033–2040. 1993. View Article : Google Scholar : PubMed/NCBI

51 

Gonzalo-Garijo MA, de Argila D, Pimentel JJ, Alejo M and García-Menaya JM: Skin reaction to contrast medium. Allergy. 52:875–876. 1997. View Article : Google Scholar : PubMed/NCBI

52 

Dillman JR, Ellis JH, Cohan RH, Strouse PJ and Jan SC: Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol. 189:1533–1538. 2007. View Article : Google Scholar : PubMed/NCBI

53 

Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD and Olivera A: Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol. 135:729–736. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Sze G, Brant-Zawadzki M, Haughton VM, Maravilla KR, McNamara MT, Kumar AJ, Aisen AM, Dreisbach JN, Bradley WG Jr and Weinreb JC: Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology. 181:693–699. 1991. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Iordache AM, Docea AO, Buga AM, Mitrut R, Albulescu D, Zlatian O, Ianosi S, Ianosi G, Neagoe D, Sifaki M, Sifaki M, et al: The incidence of skin lesions in contrast media-induced chemical hypersensitivity. Exp Ther Med 17: 1113-1124, 2019.
APA
Iordache, A.M., Docea, A.O., Buga, A.M., Mitrut, R., Albulescu, D., Zlatian, O. ... Calina, D. (2019). The incidence of skin lesions in contrast media-induced chemical hypersensitivity. Experimental and Therapeutic Medicine, 17, 1113-1124. https://doi.org/10.3892/etm.2018.7056
MLA
Iordache, A. M., Docea, A. O., Buga, A. M., Mitrut, R., Albulescu, D., Zlatian, O., Ianosi, S., Ianosi, G., Neagoe, D., Sifaki, M., Rogoveanu, O. C., Branisteanu, D. E., Calina, D."The incidence of skin lesions in contrast media-induced chemical hypersensitivity". Experimental and Therapeutic Medicine 17.2 (2019): 1113-1124.
Chicago
Iordache, A. M., Docea, A. O., Buga, A. M., Mitrut, R., Albulescu, D., Zlatian, O., Ianosi, S., Ianosi, G., Neagoe, D., Sifaki, M., Rogoveanu, O. C., Branisteanu, D. E., Calina, D."The incidence of skin lesions in contrast media-induced chemical hypersensitivity". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1113-1124. https://doi.org/10.3892/etm.2018.7056
Copy and paste a formatted citation
x
Spandidos Publications style
Iordache AM, Docea AO, Buga AM, Mitrut R, Albulescu D, Zlatian O, Ianosi S, Ianosi G, Neagoe D, Sifaki M, Sifaki M, et al: The incidence of skin lesions in contrast media-induced chemical hypersensitivity. Exp Ther Med 17: 1113-1124, 2019.
APA
Iordache, A.M., Docea, A.O., Buga, A.M., Mitrut, R., Albulescu, D., Zlatian, O. ... Calina, D. (2019). The incidence of skin lesions in contrast media-induced chemical hypersensitivity. Experimental and Therapeutic Medicine, 17, 1113-1124. https://doi.org/10.3892/etm.2018.7056
MLA
Iordache, A. M., Docea, A. O., Buga, A. M., Mitrut, R., Albulescu, D., Zlatian, O., Ianosi, S., Ianosi, G., Neagoe, D., Sifaki, M., Rogoveanu, O. C., Branisteanu, D. E., Calina, D."The incidence of skin lesions in contrast media-induced chemical hypersensitivity". Experimental and Therapeutic Medicine 17.2 (2019): 1113-1124.
Chicago
Iordache, A. M., Docea, A. O., Buga, A. M., Mitrut, R., Albulescu, D., Zlatian, O., Ianosi, S., Ianosi, G., Neagoe, D., Sifaki, M., Rogoveanu, O. C., Branisteanu, D. E., Calina, D."The incidence of skin lesions in contrast media-induced chemical hypersensitivity". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1113-1124. https://doi.org/10.3892/etm.2018.7056
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team